Blog Posts
Great strategies start with understanding People. Explore our blogs for insights on HCP and Patient intelligence, workforce engagement, data science, and the latest industry news
Connected Patient Journeys: How Message Resonance Is Redefining Engagement
Why Patient behavior is reshaping Pharma marketing strategies For years, Pharma marketing has been structured around...
Message Resonance Before Engagement: How Patient Understanding Is Reshaping HCP Conversations
How this builds on connected Patient journeys In our previous blog, we explored how connected Patient journeys and...
Motivation and Behavior: The Influence of GLP-1 Therapies Beyond Metabolic Health
GLP-1: More Than a Metabolic Hormone Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly becoming one...
The GLP-1 Narrative is Splitting: Convenience vs Coverage
The GLP-1 Inflection Point Coming out of industry news this past week are two developments that, on the surface, look...
Talking Medicines and Socialgist Partner to Capture the GLP-1 Consumer Voice from Real-Life Conversations
The GLP-1 consumer shift is clear, but the signals behind it are often hard to see. That’s why we’ve partnered with...
GLP-1s and the Information Explosion: When Consumer Curiosity Meets AI-Driven Health Decisions
The Rise of the Health-Seeking Consumer We are witnessing a fundamental shift: Patients are no longer simply passive...
Rethinking Persona Modeling in Pharma: A Missed Opportunity
The $20B Question: Why Behavior Still Feels Elusive US Pharma spends approximately $20 billion each year marketing to...
What is TMLabs? The R&D Innovation Engine Powering Predictive Intelligence in Life Sciences
What is TMLabs? The R&D Innovation Engine Powering Predictive Intelligence in Life Sciences TMLabs is the...
Message Resonance Score™: Surface the Real Market Narrative First
Data is everywhere. Competitive advantage comes from how early you see the signal and act. Most Agencies aren’t short...
When Medicines Become Subscriptions: The Blurring of Patient and Consumer
Recently a new chapter quietly began in healthcare. GLP-1 therapies, already reshaping the landscape of obesity and...
Top 8 Governance Considerations for AI in Pharma
AI Governance in Pharma: Essential Considerations for Responsible Innovation As Artificial Intelligence (AI) continues...
GLP-1s in India: A New Frontier in Affordable Weight Loss and Diabetes Care
The Patent Cliff That Changed Everything Within days of the patent expiry, Indian pharmaceutical companies launched a...